Neuroone Medical Technologies (NMTC) Notes Payables (2010 - 2024)

Neuroone Medical Technologies' (NMTC) quarterly Notes Payables came in at $121896.0 in Q1 2024, down 5.59% on a QoQ basis from $129116.0 in Q3 2023.

Neuroone Medical Technologies (NMTC) Notes Payables (2010 - 2024) Analysis & Trends

Neuroone Medical Technologies (NMTC) has 13 years of Notes Payables data on file, last reported at $121896.0 in Q1 2024.

Quarterly Notes Payables changed N/A year-over-year to $121896.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $121896.0 (changed N/A YoY) and the FY2023 annual result came in at $129116.0, changed N/A from the prior year.
Notes Payables fell to $121896.0 in Q1 2024, from $129116.0 in the prior quarter.
In the past five years, Notes Payables ranged from a high of $6.7 million in Q2 2020 to a low of $121896.0 in Q1 2024.
A 3-year average of $2.6 million and a median of $1.0 million in 2020 frame the typical range for Notes Payables.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Neuroone Medical Technologies	19.64 Mn	17.59 Mn	1.18 Mn

Download Data